RESP

Value judgments in a COVID-19 vaccination model: a case study in the need for public involvement in health-oriented modelling.

Harvard S, Winsberg E, Symons J, Adibi A. Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling. Soc Sci Med. 2021 Oct;286:114323. doi: 10.1016/j.socscimed.2021.114323.

Harvard S, Winsberg E, Symons J, Adibi A. Value judgments in a COVID-19 vaccination model: A case study in the need for public i...

Causal inference, moral intuition, and modeling in a pandemic

Harvard, S., & Winsberg, E. (2021). Causal Inference, Moral Intuition, and Modeling in a Pandemic. Philosophy of Medicine, 2(2). https://doi.org/10.5195/pom.2021.70

Harvard, S., & Winsberg, E. (2021). Causal Inference, Moral Intuition, and Modeling in a Pandemic. Philosophy of Medicine, 2(2)....

Epistemic risk in representation

Harvard S, Winsberg E. The Epistemic Risk in Representation. Kennedy Inst Ethics J. 2022;32(1):1-31. doi: 10.1353/ken.2022.0001. PMID: 35431275.

Harvard S, Winsberg E. The Epistemic Risk in Representation. Kennedy Inst Ethics J. 2022;32(1):1-31. doi: 10.1353/ken.2022.0001....

Purposes and duties in scientific modelling

Winsberg E, Harvard S. Purposes and duties in scientific modelling. J Epidemiol Community Health. 2022 Jan 13:jech-2021-217666. doi: 10.1136/jech-2021-217666.

Winsberg E, Harvard S. Purposes and duties in scientific modelling. J Epidemiol Community Health. 2022 Jan 13:jech-2021-217666....

Development of a conceptual model of childhood asthma to inform asthma prevention policies

Adibi A, Turvey SE, Lee TY, Sears MR, Becker AB, Mandhane PJ, Moraes TJ, Subbarao P, Sadatsafavi M. Development of a conceptual model of childhood asthma to inform asthma prevention policies. BMJ Open Respir Res. 2021 Nov;8(1):e000881. doi: 10.1136/bmjresp...

Adibi A, Turvey SE, Lee TY, Sears MR, Becker AB, Mandhane PJ, Moraes TJ, Subbarao P, Sadatsafavi M. Development of a conceptual...

Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease

Ahmadian S, Sin DD, Lynd L, Harrison M, Sadatsafavi M. Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2022 Nov;77(11):1079-1087. doi: 10.1136/thoraxjnl-2021-217962.

Ahmadian S, Sin DD, Lynd L, Harrison M, Sadatsafavi M. Benefit-harm analysis of azithromycin for the prevention of acute exacerb...

Cost-effectiveness of Implementing Objective Diagnostic Verification of Asthma in the United States

J Allergy Clin Immunol. 2019;S0091-6749(19)31634-3

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US

Cost Eff Resour Alloc. 2018 Jan 30;16:3

The projected economic and health burden of sub-optimal asthma control in Canada

Respir Med. 2018 May;138:7-12

Network vs. Pairwise Meta-Analyses: A Case Study of the Impact of an Evidence-Synthesis Paradigm on Value of Information Outcome

Pharmacoeconomics. 2014 Oct;32(10):995-1004

Future impact of various interventions on the burden of COPD in Canada: a dynamic population model.

PLoS One. 2012;7(10):e46746

Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study

J Allergy Clin Immunol. 2014 Oct;134(4):908-915.e3

Cost-effectiveness of bronchial thermoplasty, omalizumab, and standard therapy for moderate-to-severe allergic asthma

PLoS One. 2016 Jan 11;11(1):e0146003

A Quantitative Benefit-Risk Analysis of Isoniazid for Treatment of Latent Tuberculosis Infection Using Incremental Benefit Framework

Value Health. 2013 Jan-Feb;16(1):66-75

The projected economic and health burden of uncontrolled asthma in the United States

Am J Respir Crit Care Med. 2019 Nov 1;200(9):1102-111

Faculty of Pharmaceutical Sciences & UBC Division of Respiratory Medicine Respiratory Evaluation Sciences Program

Faculty of Pharmaceutical Sciences & UBC Division of Respiratory Medicine
Respiratory Evaluation Sciences Program